|
|||||||||||||||||||||||||
![]() |
Monday
Valeant Parkinson's Drug Cleared: "Valeant Pharmaceuticals (VRX:NYSE - news - research - Cramer's Take) said Thursday it has received U.S. clearance to begin marketing a treatment for Parkinson's disease.
The Food and Drug Administration's endorsement of the drug Zelapar concludes a protracted process for Valeant, who submitted the drug for approval in April 2002....." |